You are here: Industry Insights > ShangPharma

News List

ShangPharma and Icahn School of Medicine at Mount Sinai Forge Translational Research Collaboration biospace
January 17, 2018
ShangPharma Innovation Inc., a global venture capital firm specializing in biomedical research and development and technology, has entered a multiyear strategic partnership with Icahn School of Medicine at Mount Sinai (ISMMS)
ShangPharma Innovation enters into partnership with UCSF biospectrumasia
July 14, 2017
The partnership helps advance a major new initiative at UCSF to bridge academic research with industrial development.
A translational research collaboration biospectrumasia
June 12, 2017
Biomedical R&D is one of the most challenging areas of science across all disciplines and industries. Strategic partnerships often drive success in making the impossible possible.
ShangPharma Innovation Names New Executives-In-Residence en-cphi.cn
June 08, 2017
ShangPharma Innovation, Inc. (SPII) announced the addition of David Spellmeyer, PhD and Robert Lutz, PhD to its Executive-In-Residence (EIR) team.
ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as Senior Vice President of Business Develo en-cphi.cn
May 25, 2017
ShangPharma Innovation (SPI) today announced the appointment of Mohamad Moghadam-Tabrizi to the position of Senior Vice President, Business Development.
ShangPharma Innovation appoints new CEO biospectrumasia
April 14, 2017
ShangPharma Innovation is a newly incorporated division of the ShangPharma Group
ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner en-cphi.cn
March 27, 2017
ShangPharma announced today the intent for a strategic corporate restructuring.